MarketCap
Facebook
X
Telegram
Biophytis SA Balance Sheet 2023-2011 | BPTS
Brief overview of Biophytis SA's balance sheet structure
The balance sheet is assessed across five available annual reports spanning 2016 to 2020.
Total assets increased by +224.2%, from €8.4 million to €27.2 million. A CAGR near 34.2% points to substantial expansion.
Liabilities grew faster than assets: +426% versus +224.2%. A substantial part of expansion was externally funded.
The equity ratio equals 8.3%, with a starting level of . Stable cash flow is important under this structure.
The period ended with net cash: net debt stood at -€4 million. This supports financial flexibility.
The accumulated result is -€17.1 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.
Overall picture
Biophytis SA's balance sheet profile is moderate. It should be considered alongside profitability, cash flow and liability maturities.
Annual Balance Sheet Biophytis SA
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -4.01 M | -939 K | -8.02 M | -18.9 M | -2.12 M | -8.78 M | 715 K | 420 K | -42.9 K | - |
Long Term Debt |
- | - | - | 1.83 M | 5.4 M | 6.38 M | 661 K | 820 K | 273 K | 537 K | 330 K | 305 K | - |
Total Non Current Liabilities |
3.48 M | 4.55 M | - | 2.02 M | 5.54 M | 6.57 M | 822 K | 961 K | 428 K | 562 K | 344 K | 319 K | - |
Total Liabilities |
- | - | - | 20.4 M | 25.2 M | 14.9 M | 4.76 M | 3.87 M | 1.85 M | 1.52 M | 1.04 M | 1.08 M | - |
Retained Earnings |
- | - | - | -17.1 M | -17.8 M | -14 M | -11.4 M | -7.95 M | -3.29 M | -709 K | -522 K | - | - |
Total Assets |
12 M | 22 M | 34.9 M | 27.2 M | 17.7 M | 21.9 M | 25.9 M | 8.39 M | 13.5 M | 387 K | 628 K | 1.21 M | - |
Cash and Cash Equivalents |
5.57 M | 11.1 M | 23.9 M | 5.85 M | 6.34 M | 14.4 M | 19.9 M | - | - | - | - | - | - |
Book Value |
12 M | 22 M | 34.9 M | 6.83 M | -7.53 M | 7.01 M | 21.2 M | 4.52 M | 11.7 M | -1.13 M | -409 K | 126 K | - |
Total Shareholders Equity |
-3.89 M | -1.91 M | - | 2.27 M | -8.28 M | 7.01 M | 21.2 M | - | - | - | - | - | - |
All numbers in EUR currency
Quarterly Balance Sheet Biophytis SA
| 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Non Current Liabilities |
3.48 M | - | - | - | - | 7.41 M | - | - | - | 2.02 M | - | - | - | 5.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
12 M | - | - | - | - | 36.3 M | - | - | - | 27.2 M | - | - | - | 17.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.57 M | - | - | - | - | 23.9 M | - | - | - | 5.85 M | - | - | - | 6.34 M | - | - | - | 14.4 M | - | - | - | 19.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
12 M | - | - | - | - | 36.3 M | - | - | - | 27.2 M | - | - | - | 17.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-3.89 M | - | - | - | - | 5.7 M | - | - | - | 2.27 M | - | - | - | -8.28 M | - | - | - | 7.01 M | - | - | - | 21.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Balance Sheet is a fundamental financial report of Biophytis SA, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
France
Germany
Israel
Britain
Russia
Belgium
Cayman-islands